The Global SurgicalRobots Market by Product Type (Instruments & Accessories, and RoboticSystems (Da Vinci Surgical, ROSA, MAKO RIO, ROBODOC, and Others)), by SurgeryType (Gynecology Surgery, General Surgery, Urology Surgery, CardiovascularSurgery, Neurosurgery, Orthopedic Surgery, and Other Surgery), and by Region(North America, Latin America, Europe, Asia Pacific, the Middle East, andAfrica) is estimated US$ 3,380.3 million in 2017 and is projected to exhibit aCAGR of 13.4% over the forecast period (2017–2025).
The robotic technique are helpfuldue to smaller incisions, which lead to lower morbidity, less postoperativepain, and shorter hospital stays, that is similar to minimally invasive surgery. According to the data publishedin Frontiers in Surgery Journal in 2016, over 3,200 robotic platforms have beeninstalled worldwide and approximately 570,000 da Vinci procedures wereperformed in 2014.
Key players in the surgicalrobots market are focused on acquisition and new product launches in order toenhance their market share. For instance, Stryker acquired Mako SurgicalRobotic Systems for US$ 1.65 Bn in 2013 and in 2016, it launched Mako surgicalrobots for total knee replacement. Furthermore, in 2015, TransEnterix acquiredSOFAR Surgical Robotics unit for US$ 100 Mn. In 2016, Zimmer Biomet HoldingInc. acquired surgical robotics provider, Medtech SA, for US$ 132 Mn toincrease its portfolio and in 2016, MEDTECH received clearance from the U.S.Food and Drug Administration (FDA) to market the ROSA Spine robot in the U.S.Furthermore, in 2013, Auris Surgical Robotics acquired Hassen Medical, as theHassen Medical specialized in intravascular robotic catheter systems.
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/496
In 2016, the FDA granted 510(k)clearance to the Ares robot-assisted bronchoscopy platform developed bystealthy Auris Surgical Robotics In 2015, Smith & Nephew — a British-basedorthopedics giant — expanded its foothold in the surgical robotics market byacquiring Blue Belt Technologies and its Navio robotics system, which is aU.S.-based company.
Browse 27 Market Data Tables and32 Figures spread through 172 Pages and in-depth TOC on Surgical Robots ByProduct Type (Instruments & Accessories and Robotic Systems (Da VinciSurgical, ROSA, MAKO RIO, ROBODOC and Others)) By Surgery Type (GynecologySurgery, General Surgery, Urology Surgery, Cardiovascular Surgery,Neurosurgery, Orthopedic Surgery and Other Surgery) and By Region (NorthAmerica, Latin America, Europe, Asia Pacific, the Middle East, and Africa) -Global Forecast to 2025.
Increasing US Food and DrugAdministration approval for surgical robots is also expected to favor growth ofsurgical robots market. For instance, in October 2017, US Food and DrugAdministration (FDA) approved the Senhance system, of TransEnterix, which is arobotically assisted surgical device for minimally invasive surgeries. In 2016,U.S. FDA approved the first medical robot from Auris Surgical — a startup ledby the co-founder of Intuitive Surgical — a developer of Da Vinci robots.Furthermore, Stryker received FDA approval in August 2015, however, delayed itsworldwide sales until 2017, and so MAKO RIO was used only in 65 hospitals inthe U.S., the U.K., Australia, and Germany from 2015 –2017. In 2014, ROBODOCEncore Surgical System received 510(k) clearance from the US Food and DrugAdministration (FDA) for total hip Arthroplasty procedures.
Browse ResearchReport: https://www.coherentmarketinsights.com/market-insight/surgical-robots-market-496
Key takeaways of the market:
The global surgical robots marketis expected to exhibit a CAGR of 13.4% over the forecast period (2017–2025),with increasing adoption of surgical robots for minimally invasive surgeries.For instance, in 2016, approximately 753,000 surgical procedures were performedwith the da Vinci Surgical System, an increase of approximately 15% comparedwith approximately 652,000 procedures performed in 2015
Among surgery type segment,gynecology surgery segment is expected to exhibit a significant CAGR of 28.8%.This is owing to new product launches for application in gynecologicalsurgeries. For instance, in October 2017, the FDA approved TransEnterix’sSenhance robotic system. Moreover, established da Vinci robotic system has alsocontributed to growth of the gynecology surgery segment.
The global surgical robots marketis characterized by market expansion in Asia Pacific, North America, andEurope, which is expected to generate higher market revenue due to increasingnumber of acquisitions.
Some major players operating inthe global surgical robots market includes Intutitive Surgical, Think Surgical,TransEnterix, Zimmer Biomet, Stryker Corporation, Smith & Nephew, andMedrobotics Corporation.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/496
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consulting services,and competitive analysis through various recommendations related to emergingmarket trends, technologies, and potential absolute dollar opportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN: +050-5539-1737
